Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?

Highlights • CTC enumeration has grade A clinical validity in metastatic breast cancer. • CTC enumeration is ready to be used in certain clinical cases. • The combination of CTC enumeration and characterization has great potential.

Saved in:
Bibliographic Details
Published inCancer treatment reviews Vol. 41; no. 2; pp. 144 - 150
Main Authors Beije, Nick, Jager, Agnes, Sleijfer, Stefan
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.02.2015
Subjects
Antigens, Neoplasm - blood
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biomarkers, Tumor - blood
Breast cancer
Breast Neoplasms - blood
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Cell Adhesion Molecules - blood
Cell Count
Cell Separation - instrumentation
Circulating tumor cells
Clinical decision-making
Clinical Trials as Topic
CTC
Epithelial Cell Adhesion Molecule
Female
Hematology, Oncology and Palliative Medicine
Humans
Neoadjuvant Therapy - methods
Neoplastic Cells, Circulating
Recommendations
Recommendations
Breast cancer
CTC
Circulating tumor cells
Clinical decision-making
Online AccessGet full text

Cover

More Information
Summary:Highlights • CTC enumeration has grade A clinical validity in metastatic breast cancer. • CTC enumeration is ready to be used in certain clinical cases. • The combination of CTC enumeration and characterization has great potential.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0305-7372
1532-1967
DOI:10.1016/j.ctrv.2014.12.008